Windtree Therapeutics - Warrants (25/03/2026) (WINT+) Q3 2017 Earnings

14NovExpected
Q4 2016
Q1 2017
Q2 2017
Q3 2017
-2,970
-1,980.33
-990.66
-0.99

Details

Expected EPS
N/A
Actual EPS
-41.4
Surprise EPS
-41.4
Surprise Percent
+∞%

Description

Windtree Therapeutics - Warrants (25/03/2026) (WINT+) has reported earnings of -41.4 per share for Q3 2017.

0 Comments

Share your thoughts